Bacterial proteins and nucleic acids (None)

Bacterial proteins and nucleic acids represent a diverse array of essential molecular structures within prokaryotic cells that serve as the primary targets for antibiotic therapy (Nature Reviews Microbiology, 2017). These targets include enzymes involved in cell wall biosynthesis, such as penicillin-binding proteins (PBPs), the machinery for protein synthesis including the 30S and 50S ribosomal subunits, and enzymes critical for genetic maintenance and expression like DNA gyrase and RNA polymerase (StatPearls, 2023). By binding to these specific bacterial components, antimicrobial agents can exert bactericidal or bacteriostatic effects while ideally maintaining selective toxicity to avoid harming eukaryotic host cells (Merck Manual, 2023). However, the clinical utility of targeting these molecules is increasingly challenged by the emergence of resistance mechanisms, such as target site modification, enzymatic degradation of drugs, and efflux pumps (NIH, 2022). Understanding the structural and functional nuances of these bacterial targets is fundamental to the development of next-generation antibiotics designed to overcome multi-drug resistance. Furthermore, the interaction between drugs and these targets often depends on the ability of the drug to penetrate the bacterial cell envelope, which varies significantly between Gram-positive and Gram-negative species.

Other names

Bacterial macromoleculesMicrobial targetsProkaryotic proteins and genetic material

Inhibition of cell wall synthesis, inhibition of protein synthesis (30S or 50S ribosomal subunits), inhibition of nucleic acid synthesis (DNA gyrase or RNA polymerase), and disruption of metabolic pathways (StatPearls, 2023; Nature Reviews Microbiology, 2017).